Not investment advice. AI-generated analysis for educational purposes only.
All trading involves risk of loss. Past performance does not guarantee future results.
Full disclaimer
MRNA
HOLD
Health Care · S&P 500
Last updated: July 26, 2026 at 02:39 UTC
TRADEWISE AI SCORE
54
out of 100 — 6-factor composite
AI Debate Summary
4 AI agents (Research, Risk, Macro, Devil's Advocate) debated MRNA.
ATLAS
AVOID 72.0%
VOTE: AVOID
CONFIDENCE: 72
---
**ASSESSMENT: BEARISH**
**KEY_POINTS:**
1. **Fundamental Deterioration Hidden by Recent Momentum**: MRNA trades at negative earnings (P/E: N/A, Forward P/E: -16.35, P
Read full analysis →
SENTINEL
BUY 62.0%
VOTE: BUY
CONFIDENCE: 62
---
**ASSESSMENT: BULLISH ON SIZING AND RISK/REWARD — NOT ON EXTENDED MOMENTUM**
**KEY_POINTS:**
1. **Market Rerating Validation (Category 2: Valid Rerating)**
- MRNA is
Read full analysis →
HORIZON
HOLD 52.0%
VOTE: HOLD
CONFIDENCE: 52
---
## 1. MACRO-STOCK TRANSMISSION
**Healthcare biotech sector macro sensitivity:**
- MRNA operates in a rate-insensitive, non-discretionary healthcare sector. Biotech valu
Read full analysis →
CONTRARIAN
HOLD 58.0%
VOTE: HOLD
CONFIDENCE: 58
ADVERSARIAL CLEARANCE: PASS
---
## 1. STRONGEST BULL CASE
MRNA has a +115.5% composite momentum score (1mo/3mo/6mo/12mo weighted), +22.1% relative strength vs SPY, and sits
Read full analysis →
CONSENSUS
VETO_APPROVED — 61% agreement
Full debate reasoning available on Pro tier.
Market Regime Context
CURRENT REGIME
CHOPPY
(Day 48)
TradeWise monitors 5 market states (CALM → CRISIS) using VIX, breadth, and tail risk signals.
In CHOPPY regime, the system adjusts position limits,
trailing stops, and cash reserves automatically. Learn more about regime detection.
Get real-time AI alerts for MRNA
4 AI agents debate every trade. 6-factor scoring. Regime-adaptive risk management. 14-day free trial, no credit card.
Start Free Trial →
Frequently Asked Questions
Is MRNA a buy right now?
Based on TradeWise's 6-factor AI model, MRNA currently scores 54/100, indicating a
HOLD signal. This combines momentum, volume, trend structure,
volatility, sector relative strength, and drawdown analysis. The current market regime is
CHOPPY. Updated July 26, 2026 at 02:39 UTC.
What is the TradeWise AI score for MRNA?
MRNA has a TradeWise AI score of 54/100. Scores above 80 indicate STRONG BUY,
65-80 BUY, 45-65 HOLD, 30-45 WEAK, below 30 AVOID. Scores are updated daily based on the V56
momentum engine scanning all S&P 500 stocks.
How does MRNA compare to LLY?
Compare MRNA against sector peers using our head-to-head AI comparison tool.
Each comparison shows 6-factor score breakdown, AI debate excerpts, and regime-adjusted analysis.
See comparison →
Disclaimer: TradeWise provides AI-generated analysis for educational purposes only. This is not financial advice.
Past performance does not guarantee future results. All investing involves risk of loss. Backtested results are hypothetical.
Consult a qualified financial adviser before making investment decisions. Scores generated by the V56 momentum engine
based on Jegadeesh & Titman (1993) momentum research and Barroso & Santa-Clara (2015) volatility targeting.